POPPI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 1.597
EU - Europa 955
NA - Nord America 800
SA - Sud America 80
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 52
OC - Oceania 2
Totale 3.543
Nazione #
US - Stati Uniti d'America 745
IT - Italia 558
CN - Cina 436
SG - Singapore 379
VN - Vietnam 358
HK - Hong Kong 96
KR - Corea 86
IN - India 83
BR - Brasile 66
DE - Germania 63
GB - Regno Unito 58
FR - Francia 43
JP - Giappone 41
IE - Irlanda 40
NL - Olanda 39
CA - Canada 29
SE - Svezia 24
CI - Costa d'Avorio 20
BD - Bangladesh 19
FI - Finlandia 19
PH - Filippine 19
DK - Danimarca 18
ES - Italia 17
TW - Taiwan 17
CH - Svizzera 16
AT - Austria 12
IR - Iran 12
RU - Federazione Russa 12
TR - Turchia 12
MX - Messico 11
EG - Egitto 8
JO - Giordania 6
PL - Polonia 6
TH - Thailandia 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
MA - Marocco 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
AR - Argentina 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
ID - Indonesia 3
JM - Giamaica 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
SC - Seychelles 3
TG - Togo 3
AU - Australia 2
EC - Ecuador 2
MM - Myanmar 2
MQ - Martinica 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
RO - Romania 2
SI - Slovenia 2
UA - Ucraina 2
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
MW - Malawi 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.486
Città #
Singapore 305
Hefei 167
Bologna 162
Ashburn 107
Ho Chi Minh City 104
Hanoi 92
Hong Kong 79
Seoul 69
San Jose 66
Los Angeles 47
Milan 47
Dallas 40
Dublin 38
Santa Clara 38
Beijing 34
Tokyo 33
Genoa 26
Bengaluru 24
Council Bluffs 23
Rome 21
Abidjan 20
Da Nang 20
Chandler 18
São Paulo 18
Copenhagen 16
Lauterbourg 16
New York 16
Frankfurt am Main 15
Florence 14
Boardman 13
Hyderabad 13
Rimini 13
Atlanta 12
Helsinki 12
Amsterdam 11
Falkenstein 11
Modena 11
Montreal 11
Stockholm 11
Vienna 11
Forlì 10
London 10
Munich 10
Nanjing 10
Calcinelli 8
Haiphong 8
Nerviano 8
Philadelphia 8
Redondo Beach 8
Seattle 8
Shanghai 8
Biên Hòa 7
Buffalo 7
Cambridge 7
Düsseldorf 7
Exeter 7
Hải Dương 7
Prato 7
Toronto 7
Turin 7
Verona 7
Zurich 7
Barcelona 6
Boston 6
Brooklyn 6
Carlsbad 6
Cento 6
Chicago 6
Claymont 6
Denver 6
Fano 6
Laurel 6
Paris 6
Poplar 6
Amman 5
Mexico City 5
Minneapolis 5
Naples 5
New Taipei City 5
Parma 5
Perugia 5
Sofia 5
Southend 5
Tianjin 5
Wanchai 5
Birmingham 4
Bắc Ninh 4
Can Tho 4
Carpi 4
Chandigarh 4
Chantilly 4
Chennai 4
Hamburg 4
Imola 4
Las Vegas 4
Madīnat an Naşr 4
Manila 4
Montesilvano 4
North Charleston 4
Näfels 4
Totale 2.164
Nome #
A RAD51/BRCA2 small molecule inhibitor enhances the antineoplastic effect of the PARPi talazoparib in pancreatic cancer 363
A journey through targeting BRCA2-RAD51 protein-protein interaction to establish synthetic lethality as paradigm for anticancer drug discovery 272
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer 263
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity 251
Preomic profile of BxPC-3 cells after treatment with BRC4 228
Identification and subsequent development of RAD51-BRCA2 disruptors through a fragment-based approach 224
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer 213
Differential enantiomers activity of ARN24089 to achieve synthetic lethality in pancreatic cancer 201
HIPPO AND NECROPTOSIS PATHWAYS AS POSSIBLE PLAYERS IN THE NEURONOPATHIC GAUCHER 201
Design and synthesis of RAD51-BRCA2 protein-protein interaction disruptors to trigger synthetic lethality with Olaparib in pancreatic cancer cells 195
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and achieve synthetic lethality in pancreatic cancer cells 189
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 171
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 165
Proteomic profile of BxPC-3 cells after treatment with BRC4 133
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 116
Targeting RAD51-BRCA2 Interaction to Enhance Synthetic Lethality with Olaparib in Pancreatic Cancer: Development of a Novel Phenyl Furan-Quinoline-Carboxylic Acid Series 115
Corrigendum to “Exploring the role of TERT in thyroid cancer: A systematic review” [Crit. Rev. Oncol./Hematol. 213 (2025) 104792] (Critical Reviews in Oncology / Hematology (2025) 213, (S1040842825001805), (10.1016/j.critrevonc.2025.104792)) 97
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 90
Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells 56
Totale 3.543
Categoria #
all - tutte 7.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 1 4 1 1 0 0 2 0 4 4
2022/202399 4 6 1 6 25 6 6 1 6 1 4 33
2023/2024346 70 26 10 15 22 15 32 23 7 18 56 52
2024/2025730 52 35 37 19 118 48 62 30 41 57 80 151
2025/20262.185 176 215 177 228 172 83 303 102 335 149 95 150
2026/2027141 110 31 0 0 0 0 0 0 0 0 0 0
Totale 3.543